Silibinin is generally considered safe when administered under medical supervision. However, potential side effects may include gastrointestinal discomfort, allergic reactions, and, rarely, anaphylaxis. It is crucial to monitor patients for any adverse reactions during treatment. The safety profile of intravenous silibinin is favorable, especially when contrasted with the severe consequences of untreated toxin exposure.
